Scientific publications

Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients

Vera R (1), Otero MJ (2), Ayala de la Peña F (3), González-Pérez C (4), Peñuelas Á (5), Sepúlveda JM (6), Quer N (7), Doménech-Climent N (8,9), Virizuela JA (10), Beorlegui P (11), Gorgas MQ (12).

(1) Servicio de Oncología Médica, Complejo Hospitalario de Navarra, Calle Irunlarrea, 3, 31008, Pamplona, Navarra, Spain.
(2) Instituto para el Uso Seguro de los Medicamentos (ISMP-España), Servicio de Farmacia Hospitalaria, Hospital Universitario de Salamanca, Salamanca, Spain.
(3) Servicio de Hematología y Oncología Médica, Hospital General Universitario Morales Meseguer, Murcia, Spain.
(4) Servicio de Farmacia Hospitalaria, Hospital Clínico San Carlos, Madrid, Spain.
(5) Coordinadora de Enfermería Oncológica, Hospital Universitari Vall d'Hebron, Vall d'Hebron Instituto de Oncología, Barcelona, Spain.
(6) Servicio de Oncología Médica, Hospital Universitario Doce de Octubre, Madrid, Spain.
(7) Servicio de Farmacia Hospitalaria, Instituto Catalán de Oncología, Barcelona, Spain.
(8) Adjunta de Enfermería, Hospital Virgen de los Lirios, Alcoy, Spain.
(9) Universidad de Alicante, Alicante, Spain.
(10) Servicio de Oncología Médica, Hospital Universitario Virgen Macarena, Seville, Spain.
(11) Enfermería Clínica Avanzada, Clínica Universitaria de Navarra, Pamplona, Spain.
(12) Servicio de Farmacia Hospitalaria, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

Magazine: Clinical Translational Oncology

Date: Apr 1, 2019

Medical Oncology

AIM:

To define recommendations that permit safe management of antineoplastic medication, minimise medication errors and improve the safety of cancer patients undergoing treatment.

METHODS:

By reviewing the literature and consulting the websites of various health organisations and agencies, an expert committee from the Spanish Society of Hospital Pharmacy and the Spanish Society of Medical Oncology defined a set of safe practices covering all stages of providing cancer therapy to patients. The Spanish Society of Oncology Nursing revised and endorsed the final list.

RESULTS:

In total, 68 recommendations arranged in five sections were defined. They include issues concerning the training of health professionals, the technological resources needed, treatment planning, informing the patient and his/her family, the processes of prescribing, preparing, dispensing and administering cancer therapy (orally, parenterally or intrathecally), assessing patient adherence and treatment toxicity.

CONCLUSIONS:

It is essential for healthcare establishments to implement specific measures designed to prevent medication errors, in order to ensure the safety of cancer patients treated with antineoplastic medication.

CITATION  Clin Transl Oncol. 2019 Apr;21(4):467-478. doi: 10.1007/s12094-018-1945-x. Epub 2018 Oct 8

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra